Apple: Analysts Anticipate Q3 Revenues Of $73.3 Billion

Apple (NASDAQ: AAPL) will be reporting their fiscal third quarter on July 27th after market close. Analysts have a consensus $159.98 12-month price target on the company, via a total of 41 analysts, with 12 analysts having strong buy ratings. 21 analysts meanwhile have buy ratings, 7 have hold ratings, and one has a strong sell on the company. The street high comes from Wedbush Securities with a $185 price target, and the lowest target sits at $125 from Wolfe Research.

25 analysts have revenue estimates for the third quarter. The mean revenue estimate between all 25 analysts is $73.276 billion; this number has been revised upwards from $66.284 billion at the start of the year. The highest revenue estimate is $77.054 billion, while the lowest is $65.682 billion.

Onto EBITDA estimates, there are currently only 9 analysts who have third-quarter EBITDA estimates. The mean is currently $22.516 billion, with this number having been revised up from $18.4 billion at the start of the year. Street high is a $24.44 billion EBITDA estimate and the lowest is $18.868 billion.

Analysts estimate that quarterly earnings per share will come in at $1.01, with this number being revised up from $0.76 at the start of the year. Street high is currently $1.16 and the lowest estimate is $0.82 per share for the quarter.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

First Majestic Q1 Earnings: A Bang Up Quarter

Copper’s Structural Shortage May Be Here to Stay | Colin Joudrie – Selkirk Copper

Why Barrick’s “Strong” Quarter Wasn’t So Strong | Q1 2026 Earnings

Recommended

Questcorp Wraps Expanded Drone Survey at La Union as Summer Drilling Approaches

Altamira Gold Extends Maria Bonita Footprint with 110 Metre Step-Out

Related News

Canaccord Genuity Resumes Coverage On Xebec Adsorption With C$6 Price Target

This morning Canaccord Genuity resumed their coverage on Xebec Adsorption (TSXV: XBC) with a Speculative...

Thursday, September 17, 2020, 01:15:32 PM

Lundin Gold: Canaccord Says Fruta Del Norte Mine Ranks Among Best In World

Lundin Gold Inc. (TSX: LUG) on Tuesday provided investors with a three-year outlook. The company...

Friday, December 2, 2022, 12:36:00 PM

Lyft Sees Several Analysts Raise Targets Following Q1 Earnings

Lyft Inc (NASDAQ: LYFT) opened up 2.5% higher Tuesday morning following the release of its...

Sunday, May 9, 2021, 12:24:00 PM

Organigram: Analysts Upgrade Targets Following BAT Investment

On March 9th, Organigram Holdings (TSX: OGI) (NASDAQ: OGI) announced that they received a C$221...

Sunday, March 14, 2021, 06:32:00 PM

Haywood Initiates Coverage On Ascend Wellness With $16.50 Price Target

Haywood Capital Markets recently became the latest firm to initiate coverage on Ascend Wellness (CSE:...

Wednesday, September 1, 2021, 03:33:00 PM